Leading clinical immunology into its next chapter.
HI-Bio™ leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases (IMDs). With clinical-stage programs and pipeline, HI-Bio has the potential to address diseases across the immune landscape.
Driven to make an impact on the lives of patients with severe immune-mediated diseases? Excited to work as part of a collaborative team? Say ‘HI’ and let us get to know each other.
